| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2990.2003.00535.X |
| P8608 | Fatcat ID | release_uelztu3nyvdydo6pdpg3oa6bbi |
| P698 | PubMed publication ID | 15175080 |
| P2093 | author name string | Konstantinidou AE | |
| Korkolopoulou P | |||
| Patsouris E | |||
| Sakkas D | |||
| Perdiki M | |||
| Kavantzas N | |||
| Pavlopoulos PM | |||
| Thymara I | |||
| Thomas-Tsagli E | |||
| Rologis D | |||
| Angelidakis D | |||
| Boviatsis E | |||
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway | Q24672316 | ||
| Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1 | Q28141355 | ||
| The Expression and Distribution of the Hypoxia-Inducible Factors HIF-1α and HIF-2α in Normal Human Tissues, Cancers, and Tumor-Associated Macrophages | Q28143066 | ||
| Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha | Q28267232 | ||
| Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis | Q28279053 | ||
| Expression and distribution of vascular endothelial growth factor protein in human brain tumors | Q28304035 | ||
| Purification and characterization of hypoxia-inducible factor 1 | Q28678375 | ||
| Expression of hypoxia-inducible factor 1? in brain tumors | Q29540607 | ||
| Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma | Q31076190 | ||
| VEGF and vascular fusion: implications for normal and pathological vessels | Q33764024 | ||
| Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research | Q34174522 | ||
| VEGF in brain tumors | Q34178821 | ||
| Descriptive analysis and quantification of angiogenesis in human brain tumors | Q34178854 | ||
| Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat | Q36620026 | ||
| Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. | Q36665942 | ||
| Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer | Q42481577 | ||
| Vascular endothelial growth factor (VEGF) in astrocytic gliomas--a prognostic factor? | Q44296901 | ||
| Vascular endothelial growth factor and prognosis in patients with node-negative breast cancer | Q45714432 | ||
| Post-transcriptional regulation of vascular endothelial growth factor by hypoxia | Q48066359 | ||
| Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours | Q48089840 | ||
| Prognostic implications of microvessel morphometry in diffuse astrocytic neoplasms | Q48686235 | ||
| Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas. | Q48727704 | ||
| Expression of hypoxia-inducible factor-1 alpha in oligodendrogliomas: its impact on prognosis and on neoangiogenesis | Q48819807 | ||
| Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours. | Q54189859 | ||
| Microvessel density is a prognostic indicator for patients with astroglial brain tumors. | Q55479921 | ||
| P433 | issue | 3 | |
| P921 | main subject | hypoxia | Q105688 |
| microvessel | Q6840468 | ||
| P304 | page(s) | 267-278 | |
| P577 | publication date | 2004-06-01 | |
| P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
| P1476 | title | Hypoxia-inducible factor 1alpha/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis | |
| P478 | volume | 30 |
| Q48092237 | 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in the Preoperative Evaluation of Gliomas |
| Q42128435 | A Proposed Paradigm Shift in Initializing Cancer Predictive Models with DCE-MRI Based PK Parameters: A Feasibility Study |
| Q33402531 | A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma |
| Q50866815 | Analysis of hypoxia-inducible factor 1alpha expression and its effects on invasion and metastasis. |
| Q46454434 | Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma |
| Q88044873 | Astrocyte-derived CCL20 reinforces HIF-1-mediated hypoxic responses in glioblastoma by stimulating the CCR6-NF-κB signaling pathway |
| Q39156092 | Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner. |
| Q37808081 | Canine astrocytic tumors: a comparative review |
| Q47361436 | Comparison of the Effect of Vessel Size Imaging and Cerebral Blood Volume Derived from Perfusion MR Imaging on Glioma Grading |
| Q55460951 | Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas. |
| Q51495475 | Correlations between perfusion MR imaging cerebral blood volume, microvessel quantification, and clinical outcome using stereotactic analysis in recurrent high-grade glioma. |
| Q55469726 | Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. |
| Q29615944 | Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics |
| Q36425968 | Development of novel therapeutic strategies that target HIF-1. |
| Q40051006 | Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma |
| Q57784529 | Divergent Changes of p53 in Pulmonary Arterial Endothelial and Smooth Muscle Cells Involved in the Development of Pulmonary Hypertension |
| Q59795355 | EZH2, HIF-1, and Their Inhibitors: An Overview on Pediatric Cancers |
| Q28253053 | Evaluation of HIF-1 inhibitors as anticancer agents |
| Q38372657 | Evaluation of Hypoxia Inducible Factor-1α and Glucose Transporter-1 Expression in Non Melanoma Skin Cancer: An Immunohistochemical Study |
| Q40450064 | Evaluation of hypoxia-inducible factor 1alpha overexpression as a predictor of tumour recurrence and progression in superficial urothelial bladder carcinoma. |
| Q28275738 | Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR |
| Q30318543 | HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression |
| Q33642200 | HIF1alpha isoforms in benign and malignant prostate tissue and their correlation to neuroendocrine differentiation |
| Q27025886 | HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression |
| Q37375205 | High incidence of MGMT and RARbeta promoter methylation in primary glioblastomas: association with histopathological characteristics, inflammatory mediators and clinical outcome |
| Q48144576 | Hypoxia-inducible factor 1α expression is a prognostic biomarker in patients with astrocytic tumors associated with necrosis on MR image |
| Q36952855 | Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme |
| Q47556528 | Increased risk of brain cancer incidence in stroke patients: a clinical case series, population-based and longitudinal follow-up study |
| Q24309876 | Inhibition of Nodal suppresses angiogenesis and growth of human gliomas |
| Q48585558 | Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas |
| Q46116410 | Levels of vascular endothelial growth factor and matrix metalloproteinase-9 proteins in patients with glioma |
| Q37986039 | Molecular Imaging of Hypoxia: Strategies for Probe Design and Application |
| Q38128383 | Oxygen sensing, hypoxia-inducible factors, and disease pathophysiology |
| Q54504827 | Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas. |
| Q31062346 | Prognostic factors for anaplastic astrocytomas |
| Q34130984 | Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia |
| Q42239810 | Quantifying the role of angiogenesis in malignant progression of gliomas: in silico modeling integrates imaging and histology |
| Q36485190 | Regulation of angiogenesis by hypoxia-inducible factor 1. |
| Q37359659 | Regulation of cancer cell metabolism by hypoxia-inducible factor 1. |
| Q35759208 | Targeting Hypoxia-Inducible Factor 1α in a New Orthotopic Model of Glioblastoma Recapitulating the Hypoxic Tumor Microenvironment |
| Q33589279 | The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma |
| Q46111067 | Time course of imaging changes of GBM during extended bevacizumab treatment |
| Q48421256 | Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas |
| Q40212341 | Upregulation of frizzled 9 in astrocytomas. |
| Q28567903 | Vascular endothelial growth factor participates in modulating the C6 glioma-induced migration of rat bone marrow-derived mesenchymal stem cells and upregulates their vascular cell adhesion molecule-1 expression |
| Q35799695 | Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art. |
Search more.